O-GlcNAcylation: an Important Post-translational Modification and a Potential Therapeutic Target for Cancer Therapy

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 2022 Sep 14

PMID 36104770

Authors

Qingsong Lu

Xiaozhen Zhang

Tingbo Liang

Xueli Bai

Affiliations

Soon will be listed here.

Abstract

O-linked β-D-N-acetylglucosamine (O-GlcNAc) is an important post-translational modification of serine or threonine residues on thousands of proteins in the nucleus and cytoplasm of all animals and plants. In eukaryotes, only two conserved enzymes are involved in this process. O-GlcNAc transferase is responsible for adding O-GlcNAc to proteins, while O-GlcNAcase is responsible for removing it. Aberrant O-GlcNAcylation is associated with a variety of human diseases, such as diabetes, cancer, neurodegenerative diseases, and cardiovascular diseases. Numerous studies have confirmed that O-GlcNAcylation is involved in the occurrence and progression of cancers in multiple systems throughout the body. It is also involved in regulating multiple cancer hallmarks, such as metabolic reprogramming, proliferation, invasion, metastasis, and angiogenesis. In this review, we first describe the process of O-GlcNAcylation and the structure and function of O-GlcNAc cycling enzymes. In addition, we detail the occurrence of O-GlcNAc in various cancers and the role it plays. Finally, we discuss the potential of O-GlcNAc as a promising biomarker and novel therapeutic target for cancer diagnosis, treatment, and prognosis.

Citing Articles

Hypoxia-Induced O-GlcNAcylation of GATA3 Leads to Excessive Testosterone Production in Preeclamptic Placentas.

Liu J, Yang Y, Wu H, Dang F, Yu X, Wang F MedComm (2020). 2025; 6(3):e70115.

PMID: 39991625 PMC: 11847629. DOI: 10.1002/mco2.70115.

Inhibition of CDC27 O-GlcNAcylation coordinates the antitumor efficacy in multiple myeloma through the autophagy-lysosome pathway.

Wu H, Qin R, Li W, Liu J, Deng C, Zheng Z Acta Pharmacol Sin. 2025; .

PMID: 39984622 DOI: 10.1038/s41401-025-01500-2.

Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.

O-linked β-N-acetylglucosaminylation in lung cancer and beyond: A multidimensional perspective.

Jiang J, Huang X, Feng J, Liu L, Liu Y, Jia J Chin Med J (Engl). 2025; 138(3):355-357.

PMID: 39787372 PMC: 11771721. DOI: 10.1097/CM9.0000000000003329.

Site-specific prediction of O-GlcNAc modification in proteins using evolutionary scale model.

Khalid A, Kaleem A, Qazi W, Abdullah R, Iqtedar M, Naz S PLoS One. 2024; 19(12):e0316215.

PMID: 39739642 PMC: 11687694. DOI: 10.1371/journal.pone.0316215.

References

Ferrer C, Lynch T, Sodi V, Falcone J, Schwab L, Peacock D . O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol Cell. 2014; 54(5):820-31. PMC: 4104413. DOI: 10.1016/j.molcel.2014.04.026. View

Ali A, Kim S, Kim M, Choi M, Kang S, Cho G . O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression. Mol Cells. 2017; 40(7):476-484. PMC: 5547217. DOI: 10.14348/molcells.2017.2309. View

Akella N, Le Minh G, Ciraku L, Mukherjee A, Bacigalupa Z, Mukhopadhyay D . O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells. Mol Cancer Res. 2020; 18(4):585-598. PMC: 7127962. DOI: 10.1158/1541-7786.MCR-19-0732. View

Lynch T, Ferrer C, Jackson S, Shahriari K, Vosseller K, Reginato M . Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem. 2012; 287(14):11070-81. PMC: 3322861. DOI: 10.1074/jbc.M111.302547. View

Gu Y, Gao J, Han C, Zhang X, Liu H, Ma L . O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells. Mol Med Rep. 2014; 10(2):897-904. DOI: 10.3892/mmr.2014.2269. View

Shi Y, Tomic J, Wen F, Shaha S, Bahlo A, Harrison R . Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia. 2010; 24(9):1588-98. PMC: 4361888. DOI: 10.1038/leu.2010.152. View

Clark R, McDonough P, Swanson E, Trost S, Suzuki M, Fukuda M . Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem. 2003; 278(45):44230-7. DOI: 10.1074/jbc.M303810200. View

Gao Y, Wells L, Comer F, Parker G, Hart G . Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J Biol Chem. 2001; 276(13):9838-45. DOI: 10.1074/jbc.M010420200. View

Steenackers A, Olivier-Van Stichelen S, Baldini S, Dehennaut V, Toillon R, Le Bourhis X . Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines. Front Endocrinol (Lausanne). 2016; 7:46. PMC: 4879930. DOI: 10.3389/fendo.2016.00046. View

10.

Fulop N, Marchase R, Chatham J . Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res. 2006; 73(2):288-97. PMC: 2848961. DOI: 10.1016/j.cardiores.2006.07.018. View

11.

Zhu G, Chen X . Aptamer-based targeted therapy. Adv Drug Deliv Rev. 2018; 134:65-78. PMC: 6239901. DOI: 10.1016/j.addr.2018.08.005. View

12.

Liu L, Li L, Ma C, Shi Y, Liu C, Xiao Z . -GlcNAcylation of Thr/Ser in short-form -GlcNAc transferase (sOGT) regulates its substrate selectivity. J Biol Chem. 2019; 294(45):16620-16633. PMC: 6851338. DOI: 10.1074/jbc.RA119.009085. View

13.

Yang W, Kim J, Nam H, Ju J, Kim H, Kim Y . Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol. 2006; 8(10):1074-83. DOI: 10.1038/ncb1470. View

14.

Cervoni L, TURANO C, Ferraro A, Ciavatta P, Marmocchi F, Eufemi M . Glycosylation of RNA polymerase II from wheat germ. FEBS Lett. 1997; 417(2):227-30. DOI: 10.1016/s0014-5793(97)01285-4. View

15.

Love D, Kochan J, Cathey R, Shin S, Hanover J, Kochran J . Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci. 2003; 116(Pt 4):647-54. DOI: 10.1242/jcs.00246. View

16.

Caldwell S, Jackson S, Shahriari K, Lynch T, Sethi G, Walker S . Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene. 2010; 29(19):2831-42. DOI: 10.1038/onc.2010.41. View

17.

Bullen J, Balsbaugh J, Chanda D, Shabanowitz J, Hunt D, Neumann D . Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK). J Biol Chem. 2014; 289(15):10592-10606. PMC: 4036179. DOI: 10.1074/jbc.M113.523068. View

18.

Wells L, Vosseller K, Hart G . Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science. 2001; 291(5512):2376-8. DOI: 10.1126/science.1058714. View

19.

Hu Y, Suarez J, Fricovsky E, Wang H, Scott B, Trauger S . Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem. 2008; 284(1):547-555. PMC: 2610513. DOI: 10.1074/jbc.M808518200. View

20.

Olsen J, Vermeulen M, Santamaria A, Kumar C, Miller M, Jensen L . Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010; 3(104):ra3. DOI: 10.1126/scisignal.2000475. View